These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 34794485)
1. NeoSeq: a new method of genomic sequencing for newborn screening. Wang H; Yang Y; Zhou L; Wang Y; Long W; Yu B Orphanet J Rare Dis; 2021 Nov; 16(1):481. PubMed ID: 34794485 [TBL] [Abstract][Full Text] [Related]
2. Association Analysis of Gene Sequencing by NeoSeq Combined with Tandem Mass Spectrum and Four Neonatal Diseases. Xue S; Zhu J; Zhang H; Han L; Yang R; Dai P; Ding G Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702680 [TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing as a second-tier diagnostic test for newborn screening. Luo X; Wang R; Fan Y; Gu X; Yu Y J Pediatr Endocrinol Metab; 2018 Aug; 31(8):927-931. PubMed ID: 30030962 [TBL] [Abstract][Full Text] [Related]
4. Evaluating a Novel Newborn Screening Methodology: Combined Genetic and Biochemical Screenings. Yu B; Yang Y; Zhou L; Wang Q Arch Med Res; 2024 Feb; 55(2):102959. PubMed ID: 38295467 [TBL] [Abstract][Full Text] [Related]
5. Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency. McCandless SE; Chandrasekar R; Linard S; Kikano S; Rice L Mol Genet Metab; 2013 Jan; 108(1):51-5. PubMed ID: 23151387 [TBL] [Abstract][Full Text] [Related]
6. Applying targeted next generation sequencing to dried blood spot specimens from suspicious cases identified by tandem mass spectrometry-based newborn screening. Qian J; Wang X; Liu J; Zhong J; Le Y; Melchior Tellier LCA; Liu C; Jiang P; Gao R; Wang Y J Pediatr Endocrinol Metab; 2017 Aug; 30(9):979-988. PubMed ID: 28771436 [TBL] [Abstract][Full Text] [Related]
7. Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates. Lee H; Lim J; Shin JE; Eun HS; Park MS; Park KI; Namgung R; Lee JS Yonsei Med J; 2019 Nov; 60(11):1061-1066. PubMed ID: 31637888 [TBL] [Abstract][Full Text] [Related]
8. Abnormal biochemical indicators of neonatal inherited metabolic disease in carriers. Guo F; Zhou L; Zhang F; Yu B; Yang Y; Liu Z Orphanet J Rare Dis; 2024 Apr; 19(1):145. PubMed ID: 38575986 [TBL] [Abstract][Full Text] [Related]
9. Application of Next-Generation Sequencing Following Tandem Mass Spectrometry to Expand Newborn Screening for Inborn Errors of Metabolism: A Multicenter Study. Yang Y; Wang L; Wang B; Liu S; Yu B; Wang T Front Genet; 2019; 10():86. PubMed ID: 30838026 [TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing as a follow-up test in an expanded newborn screening programme. Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448 [TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry in clinical chemistry: the case of newborn screening. la Marca G J Pharm Biomed Anal; 2014 Dec; 101():174-82. PubMed ID: 24844843 [TBL] [Abstract][Full Text] [Related]
12. 3-Methylcrotonyl-CoA carboxylase deficiency newborn screening in a population of 536,008: is routine screening necessary? Wang H; Liu S; Wang B; Yang Y; Yu B; Wang L; Wang T J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1321-1326. PubMed ID: 31730530 [TBL] [Abstract][Full Text] [Related]
13. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates. Huang X; Wu D; Zhu L; Wang W; Yang R; Yang J; He Q; Zhu B; You Y; Xiao R; Zhao Z Orphanet J Rare Dis; 2022 Feb; 17(1):66. PubMed ID: 35193651 [TBL] [Abstract][Full Text] [Related]
14. [Newborn screening program and blood amino acid profiling in early neonates with citrin deficiency]. Tang CF; Liu SC; Feng Y; Mei HF; Liu HP; Feng JW; Ye LX; Wang GQ; Liu L; Huang YL Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):797-801. PubMed ID: 31594068 [No Abstract] [Full Text] [Related]
15. [Tandem mass spectrometry as screening for inborn errors of metabolism]. Campos H D Rev Med Chil; 2011 Oct; 139(10):1356-64. PubMed ID: 22286738 [TBL] [Abstract][Full Text] [Related]
16. Molecular genetic screening of full-term small for gestational age. Zhang S; Zhou L; Zhang L; Wang Y; Wang H BMC Pediatr; 2023 May; 23(1):217. PubMed ID: 37147621 [TBL] [Abstract][Full Text] [Related]
17. Newborn screening for the full set of mucopolysaccharidoses in dried blood spots based on first-tier enzymatic assay followed by second-tier analysis of glycosaminoglycans. Herbst ZM; Hong X; Sadilek M; Fuller M; Gelb MH Mol Genet Metab; 2023 Nov; 140(3):107698. PubMed ID: 37820575 [TBL] [Abstract][Full Text] [Related]
18. Prospective identification by neonatal screening of patients with guanidinoacetate methyltransferase deficiency. Hart K; Rohrwasser A; Wallis H; Golsan H; Shao J; Anderson T; Wang X; Szabo-Fresnais N; Morrissey M; Kay DM; Wojcik M; Galvin-Parton PA; Longo N; Caggana M; Pasquali M Mol Genet Metab; 2021; 134(1-2):60-64. PubMed ID: 34389248 [TBL] [Abstract][Full Text] [Related]
19. Inborn errors of metabolism detectable by tandem mass spectrometry in Beijing. Yang N; Gong LF; Zhao JQ; Yang HH; Ma ZJ; Liu W; Wan ZH; Kong YY J Pediatr Endocrinol Metab; 2020 May; 33(5):639-645. PubMed ID: 32304307 [TBL] [Abstract][Full Text] [Related]
20. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. la Marca G; Malvagia S; Pasquini E; Innocenti M; Donati MA; Zammarchi E Clin Chem; 2007 Jul; 53(7):1364-9. PubMed ID: 17510301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]